[144] ZEVRA THERAPEUTICS, INC. SEC Filing

Rhea-AI Filing Summary

ZEVRA THERAPEUTICS, INC. (ZVRA) filed a Form 144 disclosing a proposed sale of 19,500 common shares by an insider through Morgan Stanley Smith Barney LLC on 10/10/2025. The filing lists an aggregate market value of $210,990 and shows 56,135,091 shares outstanding, implying the sale represents a small fraction of total shares.

The securities were acquired as Restricted Stock Units and the acquisition and planned sale date are both reported as 10/10/2025. No other sales in the prior three months are reported, and the filer affirms they are not in possession of undisclosed material adverse information.

Positive

• Disclosure filed complying with Rule 144 showing proposed sale details
• No prior sales in the past three months reported for the selling person

Negative

• None.

Insights

Equity Compliance Analyst

Insider plans to sell 19,500 RSU-derived shares on 10/10/2025.

The notice shows the insider will sell 19,500 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $210,990. The shares were reported as acquired via Restricted Stock Units on the same date, indicating a contemporaneous vest-and-sell event.

Key dependencies include the accuracy of the reported acquisition date and that no other sales occurred in the prior three months (the form states "Nothing to Report"). Monitor filing-confirmed execution around 10/10/2025 for settlement details and any subsequent Form 4 or amendment within the standard reporting window.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	19500	210990.00	56135091	10/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/10/2025	Restricted Stock Units	Issuer			19500	10/10/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ZVRA's Form 144 disclose about the planned sale?

It discloses a proposed sale of 19,500 common shares through Morgan Stanley Smith Barney LLC on 10/10/2025 with an aggregate market value of $210,990.

How were the shares acquired that are being sold under the Form 144?

The filing states the shares were acquired as Restricted Stock Units with an acquisition date of 10/10/2025.

What fraction of ZVRA's outstanding shares does the proposed sale represent?

The filing lists 56,135,091 shares outstanding; the proposed sale of 19,500 shares is a small fraction of that total.

Did the filer report any securities sold in the past three months?

The filing indicates "Nothing to Report" for securities sold during the past three months.

Does the filer assert possession of any undisclosed material information?

By signing the notice the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.